Goodwin

Contact
Share
Info
100 Northern Avenue
Boston, MA 02210, United States
Phone: 617.570.1000
Fax: 617.523.1231
Areas of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Class Action
  • Criminal Law
  • Energy & Utilities
  • Environmental Law
  • Finance & Banking
  • Government
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
  • Toxic Torts
  • Transportation
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Massachusetts
  • New York
Other Countries
  • France
  • Germany
  • Hong Kong
  • United Kingdom
Number of Attorneys
800+ Attorneys

Draft Legislation Published on UK Partnership Taxation

Earlier this year, HM Revenue & Customs published various ideas to ‘clarify’ the tax treatment of partners in partnerships, as part of its response to a consultation on changes to the taxation of UK partnerships. Draft…more
 /  Business Organizations, Commercial Law & Contracts, International Law & Trade, Taxation

Federal Reserve Board Announces Penalty Against State Bank for Alleged Violation of the National Flood Insurance Act

?On September 14, the Board of Governors of the Federal Reserve System announced the execution of a settlement with a state bank concerning alleged violations of the National Flood Insurance Act (“NFIA”), 42 U.S.C. §…more
 /  Finance & Banking, Insurance

Recent IPR Updates

The PTAB has been a busy place for biologics patents in the past few weeks. Here are some of the highlights..…more
 /  Intellectual Property, Science, Computers, & Technology

VA AG Sues Open-End Credit Plan Lender

On September 13, 2017, Virginia Attorney General (“Virginia AG”) Mark R. Herring announced that it had filed suit in Virginia state court against an open-end credit plan lender for allegedly violating the Virginia Consumer…more
 /  Consumer Protection, Finance & Banking

CFPB Secures $7.9 Million Trial Verdict Against Mortgage Loan Servicer

On September 8, a federal judge in California ordered a national mortgage services company to pay a $7.9 million civil penalty based on false or misleading marketing statements it allegedly made to consumers about its mortgage…more
 /  Civil Procedure, Consumer Protection, Finance & Banking

Amgen v. Hospira: Rulings on Motions in Limine

We reported earlier this week that the district court in Amgen v. Hospira denied Hospira’s motion for summary judgment of non-infringement of its proposed biosimilar of Epogen®/Procrit® (epoetin alfa) and granted-in-part and…more
 /  Civil Procedure, Intellectual Property, Science, Computers, & Technology

The Biosimilars Council Supports Sandoz’s Preemption Position in Federal Circuit Amicus Brief

Last week the Biosimilars Council submitted an amicus brief in the Federal Circuit remand proceedings for Amgen v. Sandoz, arguing that Amgen’s state-law claims for Sandoz’s failure to comply with the patent dance’s disclosure…more
 /  Administrative Law, Civil Procedure, Civil Remedies, Intellectual Property, Science, Computers, & Technology

FDA Approves Amgen’s Biosimilar of Avastin®

Today, the FDA announced that it has approved Mvasi® (bevacizumab-awwb), Amgen’s biosimilar of Genentech’s Avastin®. According to the announcement, Mvasi® is the first biosimilar that the FDA has approved for the treatment of…more
 /  Health, Science, Computers, & Technology

BI Files Answer to AbbVie’s Complaint in Adalimumab Litigation

As we previously reported, last month AbbVie filed a complaint against Boehringer Ingelheim (BI) in the U.S. District Court for the District of Delaware regarding BI’s aBLA for a biosimilar version of AbbVie’s Humira…more
 /  Intellectual Property, Science, Computers, & Technology

Scheduling Order Entered in Janssen v. Samsung Bioepis

This morning, the district court in Janssen v. Samsung Bioepis, which concerns Samsung Bioepis’ Renflexis® (infliximab-abda) biosimilar product, entered a pretrial scheduling order. The scheduling order calls for, among other…more
 /  Civil Procedure, Intellectual Property, Science, Computers, & Technology

Financial Services Weekly News - September 2017

Editor's Note - The Roundup has been on hiatus since its August 23 edition. Since then, we have had the misfortune to witness the widespread devastation inflicted by Hurricanes Harvey and Irma. Our hearts go out to the…more
 /  Business Organizations, Consumer Protection, Finance & Banking, Science, Computers, & Technology, Securities Law

Amgen/Allergan and Pfizer Present Positive Phase 3 Data For Two Investigational Trastuzumab Biosimilars

At the European Society for Medical Oncology (“ESMO”) 2017 Congress, which was held over the past several days in Madrid, Spain, companies presented Phase 3 clinical data regarding two investigational biosimilars of Herceptin…more
 /  Health, Intellectual Property, Science, Computers, & Technology

U.S. Argues Amgen’s State Law Claim Preempted by BPCIA, Supporting Sandoz

Yesterday, in the remanded appeal in Amgen v. Sandoz, the United States submitted an amicus brief to the Federal Circuit that generally supports Sandoz’s position that Amgen’s state-law claim for an injunction under California’s…more
 /  Civil Procedure, Conflict of Laws, Intellectual Property, Science, Computers, & Technology

FDA Accepts Applications for Rituximab and Filgrastim Biosimilar Candidates

According to press releases this week, the FDA has recently accepted two new Abbreviated Biologics License Applications (aBLA) for review. First, Adello Biologics yesterday announced that the FDA has accepted its aBLA for its…more
 /  Antitrust & Trade Regulation, Science, Computers, & Technology

Amgen v. Hospira: Litigation Update

With the September 18, 2017 trial date fast approaching, the district court in Amgen v. Hospira last week denied Hospira’s motion for summary judgment of non-infringement of its proposed biosimilar of Epogen®/Procrit® (epoetin…more
 /  Civil Procedure, Intellectual Property, Science, Computers, & Technology
Showing 1-15 of 1858 Results
/
View per page
Page: of 124
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.